The DEFB1 gene rs11362 A/G genetic variant is associated with risk of developing CAD: a case-control study

References

• Gáspár R, Halmi D, Demján V, et al. Kynurenine pathway metabolites as potential clinical biomarkers in coronary artery disease. Front Immunol. 2021;12:768560. doi: 10.3389/fimmu.2021.768560.
   PubMed Web of Science ®Google Scholar
• Malakar AK, Choudhury D, Halder B, et al. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019;234(10):16812–16823. doi: 10.1002/jcp.28350.
   PubMed Web of Science ®Google Scholar
• Kulbertus H, Lancellotti P. L’athérosclérose: une maladie complexe [Atherosclerosis: a complex disease]. Rev Med Liege. 2012;67(5–6):273–278.
   PubMedGoogle Scholar
• Priyamvara A, Dey AK, Bandyopadhyay D, et al. Periodontal inflammation and the risk of cardiovascular disease. Curr Atheroscler Rep. 2020;22(7):28. doi: 10.1007/s11883-020-00848-6.
   PubMed Web of Science ®Google Scholar
• Valore EV, Park CH, Quayle AJ, et al. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest. 1998;101(8):1633–1642. doi: 10.1172/JCI1861.
   PubMed Web of Science ®Google Scholar
• Han S, Bishop BM, van Hoek ML. Antimicrobial activity of human beta-defensins and induction by Francisella. Biochem Biophys Res Commun. 2008;371(4):670–674. doi: 10.1016/j.bbrc.2008.04.092.
   PubMed Web of Science ®Google Scholar
• Fusco A, Savio V, Cammarota M, et al. Beta-defensin-2 and beta-defensin-3 reduce intestinal damage caused by Salmonella typhimurium modulating the expression of cytokines and enhancing the probiotic activity of Enterococcus faecium. J Immunol Res. 2017;2017:6976935–6976939. doi: 10.1155/2017/6976935.
   PubMed Web of Science ®Google Scholar
• Sanapalli BKR, Yele V, Kalidhindi RSR, et al. Human beta defensins may be a multifactorial modulator in the management of diabetic wound. Wound Repair Regen. 2020;28(3):416–421. doi: 10.1111/wrr.12785.
   PubMed Web of Science ®Google Scholar
• Soruri A, Grigat J, Forssman U, et al. B-defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur J Immunol. 2007;37(9):2474–2486. doi: 10.1002/eji.200737292.
   PubMed Web of Science ®Google Scholar
• Nocini R, Favaloro EJ, Sanchis-Gomar F, et al. Periodontitis, coronary heart disease and myocardial infarction: treat one, benefit all. Blood Coagul Fibrinolysis. 2020;31(6):339–345. doi: 10.1097/MBC.0000000000000928.
   PubMed Web of Science ®Google Scholar
• Frye M, Bargon J, Gropp R. Expression of humanβ-defensin-1 pro-motes differentiation of keratinocytes. J Mol Med. 2001;79(5–6):275–282. doi: 10.1007/s001090100200.
   PubMed Web of Science ®Google Scholar
• Niyonsaba F, Ushio H, Nakano N, et al. Antimicrobial peptides humanβ-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol. 2007;127(3):594–604. doi: 10.1038/sj.jid.5700599.
   PubMed Web of Science ®Google Scholar
• Niyonsaba F, Ushio H, Nagaoka I, et al. The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J Immunol. 2005;175(3):1776–1784. doi: 10.4049/jimmunol.175.3.1776.
   PubMed Web of Science ®Google Scholar
• Xie S-L, Chen Y-Y, Zhang H-F, et al. Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: implications in acute myocardial infarction. Transl Res. 2015;165(3):387–395. doi: 10.1016/j.trsl.2014.09.001.
   PubMed Web of Science ®Google Scholar
• Vardar-Sengul S, Demirci T, Sen BH, et al. Human beta defensin-1 and -2 expression in the gingiva of patients with specific periodontal diseases. J Periodontal Res. 2007;42(5):429–437. doi: 10.1111/j.1600-0765.2006.00964.x.
   PubMed Web of Science ®Google Scholar
• Hollox EJ, Barber JC, Brookes AJ, et al. Defensins and the dynamic genome: what we can learn from structural variation at human chromosome band 8p23.1. Genome Res. 2008;18(11):1686–1697. doi: 10.1101/gr.080945.108.
   PubMed Web of Science ®Google Scholar
• Sun CQ, Arnold R, Fernandez-Golarz C, et al. Human B-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res. 2006;66(17):8542–8549. doi: 10.1158/0008-5472.CAN-06-0294.
   PubMed Web of Science ®Google Scholar
• Nemeth BC, Varkonyi T, Somogyvari F, et al. Relevance of α-defensins (HNP1-3) and defensin B-1 in diabetes. World J Gastroenterol. 2014;20:9128–9137.
   PubMed Web of Science ®Google Scholar
• Prado-Montes de Oca E, Velarde-Felix JS, Rios-Tostado JJ, et al. SNP 668C (-44) alters a NF-kB1 putative binding site in non-coding strand of human B-defensin 1 (DEFB1) and is associated with lepromatous leprosy. Infect Genet Evol. 2009;9(4):617–625. doi: 10.1016/j.meegid.2009.03.006.
   PubMed Web of Science ®Google Scholar
• Sandrin-Garcia P, Brandão LAC, Guimarães RL, et al. Functional single-nucleotide polymorphism in the DEFB1 gene are associated with systemic lupus erythematosus in southern Brazilians. Lupus. 2012;21(6):625–631. doi: 10.1177/0961203312436858.
   PubMed Web of Science ®Google Scholar
• Martinez-Rios MA, Vargas-Alarcon G, Peña-Duque MA, et al. The -44 C/G (rs1800972) polymorphism of the β-defensin 1 is associated with increased risk of developing type 2 diabetes mellitus. Mol Genet Genomic Med. 2019;7(1):e00509. doi: 10.1002/mgg3.509.
   PubMed Web of Science ®Google Scholar
• Ochoa-Ramirez LA, Rodriguez Millan J, Mendoza Vázquez LF, et al. β-defensin 1 gene polymorphisms are associated with kidney disease in northwestern Mexicans with type 2 diabetes. Immunol Invest. 2021;12:1–9.
   Google Scholar
• Feng Q, Liu N, Song S, et al. Relationship between β-defensin-1 gene polymorphism and susceptibility and prognosis of acute respiratory distress syndrome. Medicine. 2019;98(5):e14131. doi: 10.1097/MD.0000000000014131.
   PubMed Web of Science ®Google Scholar
• Knuuti J, Wijns W, Saraste A, et al. ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2019;41(3):407–477. doi: 10.1093/eurheartj/ehz425.
   Web of Science ®Google Scholar
• Winther S, Schmidt SE, Rasmussen LD, et al. Validation of the European Society of Cardiology pre-test probability model for obstructive coronary artery disease. Eur Heart J. 2021;42(14):1401–1411. doi: 10.1093/eurheartj/ehaa755.
   PubMed Web of Science ®Google Scholar
• Posadas-Sánchez R, Pérez-Hernández N, Angeles-Martínez J, et al. Interleukin 35 polymorphisms are associated with decreased risk of premature coronary artery disease, metabolic parameters, and IL-35 levels: the genetics of atherosclerotic disease (GEA) study. Mediators Inflamm. 2017;2017:6012795. doi: 10.1155/2017/6012795.
   PubMed Web of Science ®Google Scholar
• DeLong DM, DeLong ER, Wood PD, et al. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA. 1986;256(17):2372–2377.
   PubMed Web of Science ®Google Scholar
• Lahiri DK, Nurnberger JI. A rapid non-enzymatic method for the preparation HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991;19(19):5444. doi: 10.1093/nar/19.19.5444.
   PubMed Web of Science ®Google Scholar
• Schaid DJ. Disease-marker association. In: Elston RC, Olson JM, Palmer L, editors. Biostatistical genetics and genetic epidemiology. Chichester: Wiley; 2002. p. 216–217.
   Google Scholar
• Clayton D. Population association. In: Balding DJ, Bishop M, Cannings C, editors. Handbook of statistical genetics. Chichester: Wiley; 2001. p. 519–540.
   Google Scholar
• Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–265. doi: 10.1093/bioinformatics/bth457.
   PubMed Web of Science ®Google Scholar
• GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348(6235):648–660. doi: 10.1126/science.1262110.
   PubMed Web of Science ®Google Scholar
• Zupin L, Robino A, Navarra CO, et al. LTF and DEFB1 polymorphisms are associated with susceptibility toward chronic periodontitis development. Oral Dis. 2017;23(7):1001–1008. doi: 10.1111/odi.12689.
   PubMed Web of Science ®Google Scholar
• Chen C, Fan X, Yu S, et al. Association between periodontitis and gene polymorphisms of hBD-1 and CD14: a meta-analysis. Arch Oral Biol. 2019;104:141–149. doi: 10.1016/j.archoralbio.2019.05.029.
   PubMed Web of Science ®Google Scholar
• Polesello V, Zupin L, Di Lenarda R, et al. DEFB1 polymorphisms and salivary hBD-1 concentration in oral lichen planus patients and healthy subjects. Arch Oral Biol. 2017;73:161–165. doi: 10.1016/j.archoralbio.2016.10.008.
   PubMed Web of Science ®Google Scholar
• Polesello V, Zupin L, Di Lenarda R, et al. Impact of DEFB1 gene regulatory polymorphisms on hBD-1 salivary concentration. Arch Oral Biol. 2015;60(7):1054–1058. doi: 10.1016/j.archoralbio.2015.03.009.
   PubMed Web of Science ®Google Scholar
• Kallel A, Ben Salem T, Hammami MB, et al. Association of systemic beta-defensin-1 and -20G/A DEFB1 gene polymorphism with Behçet’s disease. Eur J Intern Med. 2019;65:58–62. doi: 10.1016/j.ejim.2019.02.008.
   PubMed Web of Science ®Google Scholar
• Kocsis AK, Lakatos PL, Somogyvári F, et al. Association of beta-defensin 1 single nucleotide polymorphisms with Crohn’s disease. Scand J Gastroenterol. 2008;43(3):299–307. doi: 10.1080/00365520701682615.
   PubMed Web of Science ®Google Scholar